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Abstract
Introduction: Nutrient deprivation is a likely contributor to intervertebral disc (IVD) degeneration. Silent mating
type information regulator 2 homolog 1 (SIRT1) protects cells against limited nutrition by modulation of apoptosis
and autophagy. However, little evidence exists regarding the extent to which SIRT1 affects IVD cells. Therefore, we
conducted an in vitro study using human IVD nucleus pulposus (NP) cells.
Methods: Thirty-two IVD specimens were obtained from patients who underwent surgical intervention and were
categorized based on Pfirrmann IVD degeneration grades. Cells were isolated from the NP and cultured in the
presence of recombinant human SIRT1 (rhSIRT1) under different serum conditions, including 10 % (v/v) fetal bovine
serum (FBS) as normal nutrition (N) and 1 % (v/v) FBS as low nutrition (LN). 3-Methyladenine (3-MA) was used to
inhibit autophagy. Autophagic activity was assessed by measuring the absorbance of monodansylcadaverine and
immunostaining and Western blotting for light chain 3 and p62/SQSTM1. Apoptosis and pathway analyses were
performed by flow cytometry and Western blotting.
Results: Cells cultured under LN conditions decreased in number and exhibited enhanced autophagy compared
with the N condition. Medium supplementation with rhSIRT1 inhibited this decrease in cell number and induced an
additional increase in autophagic activity (P < 0.05), whereas the combined use of rhSIRT1 and 3-MA resulted in
drastic decreases in cell number and autophagy (P < 0.05). The incidence of apoptotic cell death increased under
the LN condition, which was decreased by rhSIRT1 (P < 0.05) but increased further by a combination of rhSIRT1 and
3-MA (P < 0.05). Under LN conditions, NP cells showed a decrease in antiapoptotic Bcl-2 and an increase in
proapoptotic Bax, cleaved caspase 3, and cleaved caspase 9, indicating apoptosis induction via the mitochondrial
pathway. These changes were suppressed by rhSIRT1 but elevated further by rhSIRT1 with 3-MA, suggesting an
effect of rhSIRT1-induced autophagy on apoptosis inhibition. Furthermore, the observed autophagy and apoptosis
were more remarkable in cells from IVDs of Pfirrmann grade IV than in those from IVDs of Pfirrmann grade II.
Conclusions: SIRT1 protects against nutrient deprivation-induced mitochondrial apoptosis through autophagy
induction in human IVD NP cells, suggesting that rhSIRT1 may be a potent treatment agent for human
degenerative IVD disease.
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Introduction
Lower back pain affects up to 85 % of people at some
point during their lives and causes severe incapacity that
increases medical expenses and affects the workforce [1].
In the United States, lower back pain results in annual
health care and related costs of approximately $100 bil-
lion [2]. Although the cause of lower back pain is con-
sidered to be an interdependent multifactorial process,
intervertebral disc (IVD) degeneration is one of the
major pathological processes implicated [3–5].
The IVD is structurally an avascular tissue that in-
cludes an inner nucleus pulposus (NP) surrounded by an
outer annulus fibrosus (AF), which is sandwiched be-
tween the cartilaginous endplates of contiguous vertebral
bodies. The nutritional supply to NP cells depends on
diffusion, primarily through the endplates, which is re-
duced by aging- and smoking-induced sclerosis of the
subchondral bone [6]. A loss of nutritional supply ultim-
ately leads to apoptotic cell death in the IVD [7, 8]. In
particular, apoptosis of NP cells is considered to be the
first sign of IVD degeneration [9]. Therefore, treatments
targeting cell apoptosis need to be developed to inhibit
or prevent degenerative IVD disease.
Silent mating type information regulator 2 homolog 1
(SIRT1), a mammalian homolog of silent information
regulator 2, is a nicotinamide-dependent class 3 histone
deacetylase that is essential for cell survival and in-
creases the longevity of mammalian cells under calorie
restriction [10]. In response to cellular energy loss,
SIRT1 regulates multiple cellular processes, including
the cell cycle, metabolism, and apoptosis [11, 12]. Previ-
ously, we hypothesized that SIRT1 might play an import-
ant role in homeostasis of IVD tissues, especially during
the early phase of IVD degeneration. We subsequently
revealed for the first time the expression of SIRT1 in hu-
man NP cells, which markedly increases in IVDs during
early degeneration stages, thereby promoting extracellular
matrix (ECM) metabolism and cell proliferation [13].
More recently, it has been shown that SIRT1 prevents hu-
man chondrocyte apoptosis, suppresses catabolic changes
in gene expression, and accelerates osteoarthritis in
conditional SIRT1-deficient mice [14–16]. SIRT1 has been
considered to inhibit apoptosis by deacetylation of nuclear
proteins such as p53 and nuclear factor κB (NF-κB)
[17, 18]. Thus, it is conceivable that SIRT1 is a key
regulator of mammalian musculoskeletal cell survival
through modulation of apoptosis.
SIRT1 is also known to regulate the autophagy–lyso-
some pathway [19]. Autophagy-related genes Atg5, Atg7,
and Atg8, which regulate autophagy, are deacetylated by
SIRT1 in a nicotinamide-dependent manner, and this
deacetylation is accelerated by limited nutrition [19].
Autophagy is an important cell survival mechanism acti-
vated by calorie restriction in which cells digest and
recycle their own damaged proteins and organelles [12].
It has been revealed that autophagy is associated with
certain degenerative diseases such as osteoarthritis [20],
Parkinson’s disease [21], and Alzheimer’s disease [22].
Autophagy and apoptosis are closely associated in the
pathological processes of diverse human diseases [19].
On the basis of the antiapoptotic and proautophagic
roles of SIRT1, we hypothesized that SIRT1 might play a
key role in the homeostasis of IVD cells under nutrient
deprivation at the early phase of IVD degeneration. Fur-
thermore, exogenous administration of recombinant hu-
man silent mating type information regulator 2 homolog
1 (rhSIRT1) protein into an IVD might contribute to cell
survival by inhibition of apoptosis though autophagy in-
duction. The purpose of this study was to elucidate the
effects of exogenous SIRT1 on autophagy and apoptosis
under limited nutrition in human IVD NP cells.
Methods
Ethics statement
The collection and use of human IVD specimens were
approved by the ethics committee of Kobe University
Hospital. All samples were obtained in accordance with
the World Medical Association Declaration of Helsinki
Ethical Principles for Medical Research Involving Hu-
man Subjects. This study was approved by the institu-
tional review board of Kobe University Graduate School
of Medicine. All patients provided written informed
consent.
Culture of human nucleus pulposus cells
Thirty human NP tissue samples were obtained from
consenting patients during surgical procedures (lumbar
disc herniation, 13 cases; lumbar spinal stenosis, 10
cases; idiopathic scoliosis, 9 cases). There were 18 males
and 14 females with a mean age of 32.4 years (range 11–
80 years). Degeneration grades of the IVDs were deter-
mined by magnetic resonance imaging and classified
according to the Pfirrmann grading system [23]. The de-
generation grades were represented by 9 cases of grade
II IVD and 23 cases of grade IV IVD. All Pfirrmann
grade II IVDs were obtained from young patients with
idiopathic scoliosis (Table 1). To clearly compare early
degenerative IVDs (Pfirrmann grade II) with advanced
degenerative IVDs (Pfirrmann grade IV), moderate de-
generative IVDs of Pfirrmann grade III were not ana-
lyzed in the present study.
The NP was carefully separated from the AF immediately
after surgery. The tissue specimens were centrifuged and
then subjected to sequential enzyme digestions at 37 °C
with 0.025 % (w/v) collagenase P (Roche Applied Science,
Indianapolis, IN, USA) and 0.001 % (w/v) deoxy-ribonuclease
2 (DNase 2) (Sigma-Aldrich, St Louis, MO, USA) for 12 h.
The digested NP tissues were placed in complete tissue
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culture medium consisting of Dulbecco’s modified Eagle’s
medium (DMEM; Sigma-Aldrich) supplemented with
10 % (v/v) heat-inactivated fetal bovine serum (FBS;
Sigma-Aldrich), 100 U/ml penicillin, and 100 mg/ml
streptomycin. When confluent, the NP cells were released
and transferred to 35-mm culture dishes for 3 days of
preculture at 37 °C in 20 % (v/v) O2, 5 % (v/v) CO2,
and 1000 mg/L glucose. These isolated cells were
defined as NP cells.
Treatment
To induce nutritional stress, NP cells were cultured in
DMEM supplemented with 1 % (v/v) FBS, defined as the
low nutritional (LN) condition, compared with 10 % (v/v)
FBS defined as the normal nutritional (N) condition. In
this study, to extrapolate possible clinical applications of
SIRT1 to IVDs, exogenous supplementation of rhSIRT1
(Sigma-Aldrich) and not transfection of the SIRT1-
encoding gene was employed. To inhibit autophagy, we
used 3-methyladenine (3-MA; Santa Cruz Biotechnology,
Santa Cruz, CA, USA), a specific inhibitor of the early
stages of the autophagic process.
After 3 days of preculture, the NP cells were assigned to
one of four culture groups (Table 2) as follows: group N,
normal nutritional (N) condition cultured with 10 % (v/v)
FBS; group LN, low nutritional (LN) condition cultured
with 1 % (v/v) FBS; group LN + SIRT1, low nutritional
(LN) condition cultured with 1 % (v/v) FBS and rhSIRT1
(10 μM); and group LN+ SIRT1 + 3-MA, low nutritional
(LN) condition cultured with 1 % (v/v) FBS, rhSIRT1
(10 μM), and 3-MA (5 mM). Introduction of rhSIRT1
using a protein delivery reagent with culture medium was
repeated every 3 days at the same time as media changes.
Delivery efficacy of rhSIRT1
rhSIRT1 was introduced into NP cells using Pro-
DeliverIN™ (OZ Biosciences, Marseille, France), a protein
delivery reagent, according to the manufacturer’s instruc-
tions. The delivery efficiency of Pro-DeliverIN™ in NP cells
was measured using rhSIRT1 labeled with a HiLyte Fluor™
555 Labeling Kit-NH2 (Dojindo Molecular Technology,
Rockville, MD, USA). A microscopic visual count was per-
formed as described previously to calculate the delivery ef-
ficiency of rhSIRT1 [13].
Analysis of total NP cell numbers
NP cells that were approximately 60–70 % confluent
were treated with 10 μM rhSIRT1 or 5 mM 3-MA under
N or LN conditions in six-well plates at a density of
1.5 × 105 cells/well. Briefly, after 3, 7, and 14 days of ini-
tial treatment, images of five random fields were ob-
tained with Motic Images Plus 2.2 software (Shimadzu,
Kyoto, Japan). The number of NP cells in each well was
then calculated and represented as the percentage of the
baseline cell number.
Immunohistochemical staining
After 72 h of treatment, the cells were fixed in 4 % (w/v)
paraformaldehyde/phosphate-buffered saline (PBS) for
15 minutes at room temperature, permeabilized, and
blocked in 0.2 % (v/v) Triton X-100 in PBS for 30 mi-
nutes. To analyze autophagy, the cells were incubated
with a primary antibody against human light chain 3
(LC3; Santa Cruz Biotechnology) overnight at 4 °C,
followed by an Alexa Fluor 594–conjugated secondary
antibody (Invitrogen, Carlsbad, CA, USA) for 30 minutes
at room temperature. Images were obtained using a BZ-
9000 microscope (Keyence, Osaka, Japan).
Analysis of autophagy activity
Autophagy activity was assessed by using an autophagy
staining kit (Cayman Chemical, Ann Arbor, MI, USA).
The absorbance of monodansylcadaverine (MDC), which
enters multilamellar bodies by both an ion-trapping
mechanism and interactions with membrane lipids as a
probe to detect autophagic vacuoles, was measured
using a microplate reader after 6, 12, 24, 48, and 72 h of
treatment. Autophagy activity was calculated as the
MDC absorbance normalized to the cell number.
Analysis of apoptosis
Apoptosis was assessed using a MEBCYTO apoptosis kit
(MBL International, Nagoya, Japan) and flow cytometry.
Early apoptotic cells stained only with annexin V conju-
gated with fluorescein isothiocyanate (annexin V-FITC),
Table 1 Human nucleus pulposus tissue sampling
Pfirrmann grade II Pfirrmann grade IV P value
(n = 9) (n = 23)
Mean age (yr) 13.6 ± 1.5 39.8 ± 11.5 <0.01







Table 2 Experimental groups
Culture groups Culture conditions
Group N DMEM with 10 % (v/v) FBS
Group LN DMEM with 1 % (v/v) FBS
Group LN + SIRT1 DMEM with 1 % (v/v) FBS + 10 μM
rhSIRT1
Group LN + SIRT1 + 3-MA DMEM with 1 % (v/v) FBS + 10 μM
rhSIRT1 + 5 mM 3-MA
Abbreviations: DMEM Dulbecco’s modified Eagle’s medium, FBS fetal bovine
serum, LN low nutrition, 3-MA 3-methyladenine, N normal nutrition, rhSIRT1
recombinant human silent mating type information regulator 2 homolog 1,
SIRT1 silent mating type information regulator 2 homolog 1
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and late apoptotic/necrotic cells stained with propidium
iodide (PI) as well as annexin V-FITC. After 3, 7, and
14 days of treatment, treated NP cells were isolated, cen-
trifuged, and then incubated in 100 μl binding buffer
containing annexin V-FITC and PI. Apoptotic cells, indi-
cated by positive staining for annexin V-FITC only or
annexin V-FITC and PI, were counted by flow cytometry
and represented as the percentage of the total cell
number.
Sodium dodecyl sulfate-polyacrylamide gel electrophoresis
and Western blotting
Treated NP cells were lysed on ice for 30 minutes in lysis
buffer containing protease and phosphatase inhibitors
(Roche Diagnostics, Basel, Switzerland). Total cellular pro-
teins were centrifuged and collected. The separated
proteins were transblotted electrically onto a blotting
membrane (Amersham Biosciences, Arlington Heights,
IL, USA). The membranes were probed with primary anti-
bodies followed by a horseradish peroxidase–conjugated
secondary antibody. Proteins were visualized with ECL
Plus reagent (Amersham Biosciences) and a Chemilumino
analyzer LAS-3000 mini (Fujifilm, Tokyo, Japan). The ex-
pression of acetylated and total p53, as well as of acety-
lated and total NF-κB proteins, was detected to elucidate
the deacetylation potential of SIRT1. LC3 and p62 pro-
tein/sequestome 1 (p62/SQSTM1) were detected to moni-
tor autophagy. In addition, Bcl-2-associated X protein
(Bax), B-cell lymphoma (Bcl-2), caspase 3, and caspase 9
proteins were analyzed to determine the involved path-
ways of SIRT1 during apoptosis. The intensities of the
bands were quantified using ImageJ analysis software, ver-
sion 1.45 (NIH Image; National Institutes of Health,
Bethesda, MD, USA). The antibodies used in this study
were as follows: rabbit monoclonal or polyclonal anti-
bodies against acetylated and total p53, acetylated and
total NF-κB, LC3, p62/SQSTM1, Bax, Bcl-2, caspases 3
and 9, and cleaved caspases 3 and 9 (Cell Signaling Tech-
nology, Danvers, MA, USA); a mouse-monoclonal anti-
body against α-tubulin (Sigma-Aldrich); and horseradish
peroxidase–conjugated anti-rabbit and anti-mouse anti-
bodies (Amersham Biosciences).
Statistical analysis
Data are expressed as the mean ± standard deviation.
Three-way analysis of variance with the Tukey–Kramer
post hoc test was used to assess differences in experi-
mental groups. Student’s t test was used to evaluate dif-
ferences between the Pfirrmann grades II and IV groups.
P values <0.05 were regarded as statistically significant.
Statistical analyses were performed using PASW Statis-
tics 18 (IBM SPSS, Armonk, NY, USA).
Results
Introduction of recombinant human SIRT1 into nucleus
pulposus cells under low nutritional conditions maintained
deacetylation potential
The delivery efficiency of 10 μM rhSIRT1 using protein
delivery reagent was 37.9 % in our previous study [13].
In the Pfirrmann grade II IVD (n = 1), introduction of
rhSIRT1 reduced acetylated p53 but did not reduce acet-
ylated NF-κB levels. In Pfirrmann grade IV IVDs (n = 4),
introduction of rhSIRT1 reduced both acetylated p53
and acetylated NF-κB levels. This acetylation potential of
rhSIRT1 was more prominent in Pfirrmann grade IV
IVDs than in the Pfirrmann grade II IVDs. These find-
ings indicate the deacetylation potential of rhSIRT1
under LN conditions (Fig. 1a, b).
Recombinant human SIRT1 inhibited the decrease in
nucleus pulposus cell number under low nutritional
conditions
In this experiment, morphological changes were not ob-
served in any experimental group (Fig. 2a).
In Pfirrmann grade II IVDs (n = 5), the total number of
NP cells in group N showed a time-dependent increase
over 14 days (day 14 + 52.2 % vs. day 0). NP cells were
treated with each condition in six-well plates at a relatively
high density of IVD cells (approximately 50–60 % conflu-
ent). NP cells did not double, even after 14 days of culture
in 10 % (v/v) serum-supplemented media. This result sug-
gests the very slow cell proliferation of human NP cells or
reduced cell division due to the confluence in our cell cul-
ture system. The total number of NP cells in group LN +
SIRT1 showed a slight increase and was significantly
higher than that in group LN at only day 14 (P < 0.05). In
addition, the total NP cell number in group LN + SIRT1 +
3-MA was significantly lower than that in group LN+
SIRT1 at every time point (P < 0.05) (day 14, group
LN: −22 %, group LN + SIRT1: −18 %, group LN +
SIRT1 + 3-MA: −32 % vs. Group N) (Fig. 2b). In Pfirrmann
grade IV IVDs (n = 5), the number of NP cells in group N
showed a time-dependent increase (day 14 + 27.3 % vs. day
0). Cell numbers in group LN were significantly lower than
those in group N at every time point (P < 0.01). The num-
ber of NP cells in group LN+ SIRT1 showed a time-
dependent increase with a significant difference compared
with that in group LN at days 7 and 14. However, NP cell
number in group LN+ SIRT1 + 3-MA was significantly
lower than that in group LN+ SIRT1 at days 7 and 14 (P <
0.05) (day 14, group LN: −22 %, group LN + SIRT1: −8 %,
group LN+ SIRT1 + 3-MA: −34 % vs. Group N) (Fig. 2b).
Recombinant human SIRT1 accelerated autophagy
activity under low nutrition conditions
First, autophagy was quantitatively evaluated by the ab-
sorbance of MDC. In Pfirrmann grade II IVDs (n = 5),
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the normalized autophagy activity of NP cells in group
N showed no significant alteration for 72 h. Autophagy
activity in groups LN and LN + SIRT1 was significantly
higher than that in group N at 24 h (P < 0.01). However,
there was no significant difference in normalized au-
tophagy activity between groups LN and LN + SIRT1.
Autophagy activity in group LN + SIRT1 + 3-MA was
significantly lower than that in group LN + SIRT after
12 h (P < 0.01) (24 h, group LN: +115 %, group LN +
SIRT1: +88 %, group LN + SIRT1 + 3-MA: −14 % vs.
group N) (Fig. 3a). In Pfirrmann grade IV IVDs (n = 5),
the normalized autophagy activity in group N showed
no significant alteration for 72 h. Autophagy activity in
group LN was higher than that in group N after 24 h.
Moreover, autophagy activity of NP cells was signifi-
cantly stimulated in group LN + SIRT1 compared with
group LN after 48 h (P < 0.05). However, autophagy
activity in group LN+ SIRT1 + 3-MA was significantly
lower than that in group LN+ SIRT1 after 48 h (P < 0.01)
(72 h, group LN: +66 %, group LN+ SIRT1: +136 %, group
LN+ SIRT1 + 3-MA: +21 % vs. group N) (Fig. 3a).
Next, immunofluorescence analysis for LC3 was per-
formed at 72 h after treatment. In Pfirrmann grade II IVDs,
immunoreactivity for LC3 was measured in group N, as the
basal level, which showed little difference among groups N,
LN, and LN+ SIRT1. In Pfirrmann grade IV IVDs, LC3 im-
munoreactivity of group LN was higher than that of group
N. Furthermore, LC3 immunoreactivity in group LN+
SIRT1 was higher than that in groups N and LN. However,
in group LN+ SIRT1 + 3-MA, LC3 immunoreactivity was
attenuated, together with a decrease in the number of NP
cells (Fig. 3b).
Finally, we examined autophagic flux by monitoring
LC3 and p62/SQSTM1 at 72 h after treatment. LC3-I
Fig. 1 Deacetylation potential of recombinant human silent mating type information regulator 2 homolog 1 (rhSIRT1) introduced into human
nucleus pulposus cells. a Western blot analysis of acetylated and total p53, and acetylated and total nuclear factor κB (NF-κB) in nucleus pulposus
cells from intervertebral discs (IVDs) of Pfirrmann grades II and IV after 72 h of treatment with 10 μM rhSIRT1 under normal nutrition (N) conditions
with 10 % (v/v) fetal bovine serum (FBS) or low nutrition (LN) conditions with 1 % (v/v) FBS. Cells introduced with a nonspecific protein, R-phycoerythrin,
were used as the control. α-Tubulin was used as the loading control. b Ratio of acetylated p53 to total p53 and acetylated NF-κB to total NF-κB. Data are
expressed as the mean ± standard deviation (n = 1 for cells from grade II IVD and n = 4 for cells from grade IV IVDs). *P< 0.05; †P< 0.01, three-way analysis
of variance with the Tukey–Kramer post hoc test
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expression levels were quite low, making it difficult to
measure the ratio of LC3-II/LC3-I. Therefore, we mea-
sured the expression level of LC3-II compared with that
of tubulin. In the Pfirrmann grade II IVD (n = 1), Western
blot analysis revealed the SIRT1 treatment did not affect
protein expression. In Pfirrmann grade IV IVDs (n = 3), a
significant increase in the amount of LC3-II was detected
in group LN + SIRT1 compared with group LN and LN +
SIRT1 + 3MA (P < 0.05). In addition, the amount of p62/
SQSTM1 in group LN + SIRT1 was significantly decreased
compared with the other groups (P < 0.05) (Fig. 3c, d).
Recombinant human SIRT1 attenuated apoptosis under
the low nutrition conditions
In Pfirrmann grade II IVDs (n = 5), apoptosis in group
N, as detected by flow cytometry, was not altered for
14 days. Apoptosis in group LN + SIRT1 was also un-
altered for 14 days. However, the extent of apoptosis in
group LN + SIRT1 + 3-MA was significantly increased
compared with that of group LN + SIRT1 at days 7 and
14 (P < 0.01) (day 14, group N: 9 %, group LN: 14 %,
group LN + SIRT1: 10 %, group LN + SIRT1 + 3-MA:
16 %). In Pfirrmann grade IV IVDs (n = 8), the extent of
apoptosis in group LN, LN + SIRT1, and LN + SIRT1 +
3-MA was higher than that in Pfirrmann grade II IVDs.
Apoptosis in group N was maintained at the initial level
at day 3. In group LN, apoptosis increased in a time-
dependent manner compared with group N at every
time point (P < 0.01). The apoptotic incidence of group
LN + SIRT1 was also increased compared with that of
group N at day 7 (P < 0.01), but it was significantly lower
than that of group LN at every time point (P < 0.05).
Fig. 2 Effect of recombinant human silent mating type information regulator 2 homolog 1 (rhSIRT1) on the number of human nucleus pulposus
(NP) cells. a Morphological appearance of NP cells from intervertebral discs (IVDs) of Pfirrmann grade II and IV after 14 days of treatment with
10 μM rhSIRT1 or 5 mM 3-methyladenine (3-MA) under normal nutrition (N) conditions with 10 % (v/v) fetal bovine serum (FBS) or low nutrition
(LN) conditions with 1 % (v/v) FBS (bars, 250 μm). b Changes in the number of NP cells from IVDs of Pfirrmann grades II and IV after 0, 3, 7, and
14 days of treatment. Data are expressed as the mean ± standard deviation (n = 5). *P < 0.05; †P < 0.01, three-way analysis of variance with the
Tukey–Kramer post hoc test
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Fig. 3 (See legend on next page.)
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Group LN + SIRT1 + 3-MA demonstrated the highest
levels of apoptosis among all groups (P < 0.01) (day 14,
group N: 9 %, group LN: 24 %, group LN + SIRT1: 14 %,
group LN + SIRT1 + 3-MA: 29 %) (Fig. 4a, b). On the
basis of our results, basal levels of apoptosis in group N
were not so high. This may indicate physiological cell life
turnover or programmed cell death. Treatment with
rhSIRT1 can suppress limited nutrition-induced non-
physiological apoptosis, but it may not affect physio-
logical apoptosis.
Recombinant human SIRT1 modulated the mitochondrial
apoptotic pathway under low nutrition conditions
Apoptotic pathway proteins were analyzed in Pfirrmann
grade IV IVDs (n = 4) by Western blotting. Higher
amounts of both cleaved caspases 3 and 9 were detected
in group LN compared with group N. In addition, Bax
protein expression was increased and Bcl-2 was attenu-
ated in group LN. However, this enhancement of both
cleaved caspases 3 and 9 protein expression in group LN
was counteracted in group LN + SIRT1. Moreover, Bax
expression was attenuated and Bcl-2 was increased in
group LN + SIRT1. This observation shows that rhSIRT1
has an antiapoptotic effect mediated through the mito-
chondrial pathway under LN conditions. Furthermore,
when autophagy was inhibited by 3-MA, rhSIRT1-
induced antiapoptosis was attenuated in group LN +
SIRT1 + 3-MA (Fig. 5a, b).
Discussion
In the present study, we demonstrate that reduced nutri-
tion induced apoptosis through the mitochondrial path-
way in human IVD NP cells and that rhSIRT1 prevented
this apoptosis as well as induced autophagy. Pharmaco-
logical inhibition of autophagy resulted in a marked in-
crease in apoptosis, suggesting an antiapoptotic effect of
rhSIRT1 through induction of autophagy. Furthermore,
these effects of rhSIRT1 on autophagy and apoptosis in
human NP cells were more prominent in Pfirrmann
grade IV IVDs than in Pfirrmann grade II IVDs.
Published evidence suggests that excessive apoptosis of
IVD cells is a potential cause of IVD degeneration [3, 5,
24, 25]. Sudo et al. demonstrated that serum starvation
and annular needle puncture models induce apoptosis
leading to IVD degeneration, and they also revealed that
both Bcl-2 overexpression and caspase 3 knockdown
prevent apoptosis and degenerative alterations [26, 27].
We also found that apoptosis of both AF and NP cells is
mediated through the mitochondrial pathway in a rat tail
static compression model of disc degeneration [28]. In
surgically obtained herniated IVDs, Park et al. revealed
that NP cell apoptosis is also induced by the mitochon-
drial pathway [9]. Consequently, prevention of apoptosis
in NP cells is considered to be a therapeutic strategy for
IVD regeneration. In the present study, reduced serum
concentrations induced apoptosis in both early and ad-
vanced degenerative IVDs. This proapoptotic effect in-
duced by nutritional stress was more remarkable in
advanced degenerative IVDs than in early degenerative
IVDs. On the basis of these results, advanced degenera-
tive NP cells are supposed to be more sensitive to nutri-
tional stress than early degenerative NP cells, leading to
apoptosis more readily.
Researchers in several studies have reported that pre-
vention of apoptosis by platelet-derived growth factor
[29], Bcl-2 [27], caspase 3 small interfering RNA (siRNA)
[26], or a caspase inhibitor [30] has positive effects on
ECM metabolism in IVD cells. In the current study, intro-
duced rhSITR1 reduced apoptosis under LN conditions in
human NP cells from Pfirrmann grades II and IV IVDs.
Furthermore, this antiapoptotic effect of rhSIRT1 was at-
tenuated by 3-MA, an inhibitor of autophagy. Therefore,
introduced rhSIRT1 prevented apoptosis through autoph-
agy induction. In addition, apoptosis inhibition was more
obvious in Pfirrmann grade IV IVDs than in Pfirrmann
grade II IVDs. We also found that introduced rhSIRT1 re-
duced acetylation of p53, decreased proapoptotic Bax ex-
pression, apoptotic cleavage of caspases 3 and 9, and
increased antiapoptotic Bcl-2 expression in human NP
cells. It has been shown that deacetylation of p53 by
SIRT1 contributes to inhibition of p53-dependent mito-
chondrial apoptosis [18, 31]. Thus, introduced rhSIRT1
potentially contributes to NP cell survival by modulation
of the mitochondrial apoptotic pathway.
(See figure on previous page.)
Fig. 3 Effect of recombinant human silent mating type information regulator 2 homolog 1 (rhSIRT1) on the level of autophagy in human nucleus
pulposus (NP) cells. a Changes in the normalized autophagy activity of NP cells from intervertebral discs (IVDs) of Pfirrmann grades II and IV after 0, 6,
12, 24, 48, and 72 h of treatment with 10 μM rhSIRT1 or 5 mM 3-methyladenine (3-MA) under normal nutrition (N) conditions with 10 % (v/v) fetal
bovine serum (FBS) or low nutrition (LN) conditions with 1 % (v/v) FBS. Autophagy activity was measured by the absorbance of monodansylcadaverine
and normalized to the cell number. Data are expressed as the mean ± standard deviation (n = 5). *P < 0.05; †P < 0.01, three-way analysis of variance with
the Tukey–Kramer post hoc test. b Immunofluorescence images of light chain 3 (LC3) in NP cells from IVDs of Pfirrmann grades II and IV after 72 h of
treatment. 4′,6-Diamino-2-phenylindole (DAPI) was used for counterstaining. Red fluorescence indicates LC3, and blue fluorescence indicates nuclei (bars,
100 μm). c Western blot analysis of LC3 and p62/SQSTM1 in NP cells from IVDs of Pfirrmann grades II and IV after 72 h of treatment. α-Tubulin was
used as the loading control. d Ratio of LC3-II to tubulin and p62 protein/sequestome 1 (p62/SQSTM1) to tubulin. Data are expressed as the mean ±
standard deviation (n = 1 for cells from the grade II IVD and n = 3 for cells from grade IV IVDs). *P < 0.05; †P < 0.01, three-way analysis of variance with
the Tukey–Kramer post hoc test
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Autophagy is one type of cytoprotective process and
ameliorates various types of cell stress. Activation of au-
tophagy improves cell survival, whereas inhibition of au-
tophagy promotes cell death [32]. Autophagy is known
to be activated by a variety of stress stimuli, including
calorie restriction [33], hypoxia [34], and DNA damage
[35]. In addition, SIRT1 serves to activate autophagy
under limited nutrition [19]. In the present study,
introduced rhSIRT1 activated autophagy in NP cells
under nutrient starvation and increased the number of
NP cells through suppression of apoptosis that was
inhibited by autophagy, which is in line with previous
evidence.
Mounting evidence has indicated possible crosstalk be-
tween autophagy and apoptosis pathways. The interplay
between autophagy and apoptosis may be important
Fig. 4 Effect of recombinant human silent mating type information regulator 2 homolog 1 (rhSIRT1) on apoptosis of human nucleus pulposus
cells. a Flow cytometric analysis of annexin V conjugated with fluorescein isothiocyanate (Annexin V-FITC) and propidium iodide–stained nucleus
pulposus cells from intervertebral discs (IVDs) of Pfirrmann grades II and IV after 3, 7, and 14 days of treatment with 10 μM rhSIRT1 or 5 mM
3-methyladenine (3-MA) under normal nutrition (N) conditions with 10 % (v/v) fetal bovine serum (FBS) or low nutrition (LN) conditions with 1 %
(v/v) FBS. b Changes in the percentage of apoptotic NP cells from IVDs of Pfirrmann grades II and IV after 3, 7, and 14 days of treatment. Data are
expressed as the mean ± standard deviation (n = 5 for cells from grade II IVDs and n = 8 for cells from grade IV IVDs). *P < 0.05; †P < 0.01, three-way
analysis of variance with the Tukey–Kramer post hoc test
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throughout development and homeostasis [36, 37]. In-
hibition of autophagy by 3-MA or siRNA targeting genes
related to autophagy triggers apoptosis in human HeLa
cells [33]. Shen et al. reported activation of autophagy in
IVDs by interleukin-1β in rat AF cells under serum
deprivation. Upon inhibition of autophagy by 3-MA,
apoptosis was increased in AF cells. They concluded that
autophagy might protect against apoptosis of AF cells as
well as against IVD degeneration [38]. The results of the
present study demonstrate that autophagy, which was
activated by rhSIRT1, inhibited apoptosis, leading to in-
creases in the number of human NP cells. Notably, this
effect of autophagy was more prominent in advanced
degenerative IVDs. These findings suggest that autoph-
agy plays an important role in the IVD degeneration
process.
Distinct apoptotic and autophagic responses to rhSIRT1
in NP cells from Pfirrmann grade IV IVDs, compared with
those from Pfirrmann grade II IVDs, may be due to differ-
ent disease types and degeneration severity. We have pre-
viously reported that SIRT1 mRNA expression is higher in
Pfirrmann grade III IVDs than in Pfirrmann grades II and
IV IVDs [13]. We considered that SIRT1 expression might
be induced in the early stage of IVD degeneration when
the internal environment of the IVD begins to deteriorate
because of disturbances in the nutrient supply and that it
Fig. 5 Effect of recombinant human silent mating type information regulator 2 homolog 1 (rhSIRT1) on apoptosis mediated through the
mitochondrial pathway in human nucleus pulposus cells. a Western blot analysis of Bcl-2-associated X protein (Bax), Bcl-2, full-length caspases 3
and 9, and cleaved caspases 3 and 9 in nucleus pulposus cells from intervertebral discs of Pfirrmann grade IV after 72 h of treatment with 10 μM
rhSIRT1 or 5 mM 3-methyladenine (3-MA) under normal nutrition (N) conditions with 10 % (v/v) fetal bovine serum (FBS) or low nutrition (LN)
conditions with 1 % (v/v) FBS. α-Tubulin was used as a loading control. b Ratio of Bax to Bcl-2 and cleaved caspases 3 and 9 to tubulin. Data are
expressed as the mean ± standard deviation (n = 4). *P < 0.05; †P < 0.01, three-way analysis of variance with the Tukey–Kramer post hoc test
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then decrease in the advanced stage of IVD degeneration.
The role of SIRT1 was altered according to IVD degener-
ation severity. The results, which show that the sensitivity
to rhSIRT1 was different between Pfirrmann grades II and
IV IVDs, indicate the safety and effectiveness of rhSIRT1
as a therapeutic agent for the treatment of degenerative
IVD disease.
The present study may be limited regarding the type of
cells employed in experiments. We used only NP cells in
this study, but both NP and AF cells are involved in the
mechanisms of IVD degeneration. Moreover, the experi-
ments were conducted using monolayer cultures with
1000 mg/L glucose and 10 % (v/v) FBS, 20 % (v/v) oxygen,
and a neutral pH. However, in human IVDs, the central
NP is hypoxic and the oxygen concentration is <1 % (v/v)
[8]. Therefore, our culture conditions do not reflect the
in vivo situation. It is now evident that nutrients, oxygen
levels, and pH are powerful regulators of cellular activity
and gene expression in IVDs, which can strongly influence
the rates of ECM synthesis and degradation, and even cell
viability [7, 39, 40]. This is a limitation of the present
study. In addition, we chose a low serum environment of
1 % (v/v) FBS supplementation as a condition of nutrient
deprivation because serum interacts with other nutrients
and plays a major role in IVD cells [40]. Serum withdrawal
to 1 % (v/v) FBS supplementation has been used as a posi-
tive apoptosis control for human AF cells in vitro and re-
sulted in a significantly greater apoptosis incidence
compared with the 20 % (v/v) FBS negative control [29].
However, it remains to be elucidated whether this serum
concentration is an acceptably low nutritional condition
for human IVD cells. Therefore, the effects of rhSIRT1
should be confirmed in vivo. In addition, SIRT1 is widely
involved in the regulation of cellular processes [11, 12].
SIRT1 may also be directly involved in cell proliferation,
as shown by the increases in cell number, or it may affect
apoptosis through pathways other than autophagy. Fur-
ther investigations need to be conducted.
Conclusions
We demonstrate that limited nutrition induced apop-
tosis through the mitochondrial pathway and that
rhSIRT1 prevented apoptosis of human NP cells through
acceleration of autophagy. Furthermore, the effects of
rhSIRT1 on autophagy and apoptosis in human NP cells
were stronger in Pfirrmann grade IV IVDs than in Pfirr-
mann grade II IVDs. The actions of rhSIRT1 in human
NP cells depend on the degeneration grade of the IVD.
SIRT1 may be a potential candidate as a novel treatment
agent for degenerative IVD disease.
Abbreviations
AF: annulus fibrosus; Annexin V-FITC: annexin V conjugated with
fluorescein isothiocyanate; Atg: autophagy-related gene; Bax: Bcl-2-
associated X protein; Bcl-2: B-cell lymphoma; DMEM: Dulbecco’s modified
Eagle’s medium; ECM: extracellular matrix; FBS: fetal bovine serum;
IVD: intervertebral disc; LC3: light chain 3; LN: low nutrition; 3-MA:
3-methyladenine; MDC: monodansylcadaverine; N: normal nutrition;
NF-κB: nuclear factor κB; NP: nucleus pulposus; PBS: phosphate-buffered
saline; PI: propidium iodide; rhSIRT1: recombinant human silent mating
type information regulator 2 homolog 1; siRNA: small interfering RNA;
SIRT1: silent mating type information regulator 2 homolog 1;
SQSTM1: sequestome 1.
Competing interests
The authors declare that they have no competing interests.
Authors’ contributions
SM carried out all studies; participated in study conception and design,
acquisition of data, analysis and interpretation of data; and wrote the
manuscript. KK participated in study conception and design, secured
funding, cowrote the manuscript, and helped to revise the manuscript.
TY participated in the design of the study, conducted experiments, and
contributed to drafting and revising the manuscript. KM and TT participated
in the design of the study, conducted experiments, performed statistical
analyses, and contributed to drafting and revising the manuscript. ZZ, YT,
TK, MI, and TU acquired and interpreted data and helped with drafting the
manuscript. TM, RK, and MK participated in study conception and
contributed to drafting the final manuscript. KN participated in study
conception and design and contributed to drafting and revising the
manuscript. All authors read and approved the final manuscript.
Acknowledgements
We thank Drs Koki Uno and Teppei Suzuki for their generous assistance and Dr
Mitchell Arico for help with preparing the manuscript. This work was supported
by a Grant-in-Aid for Scientific Research and Young Scientists (B) 23791639 from
the Ministry of Education, Culture, Sports, Science and Technology of Japan
(grant 1302-18300169).
Author details
1Department of Orthopaedic Surgery, Kobe University Graduate School of
Medicine, 7-5-1 Kusunoki-cho, Chuo-ku, Kobe 650-0017, Japan. 2Division of
Rehabilitation Medicine, Kobe University Graduate School of Medicine, 7-5-1
Kusunoki-cho, Chuo-ku, Kobe 650-0017, Japan.
Received: 7 April 2015 Accepted: 24 August 2015
References
1. Andersson GB. Epidemiological features of chronic low-back pain. Lancet.
1999;354:581–5.
2. Katz JN. Lumbar disc disorders and low-back pain: socioeconomic factors
and consequences. J Bone Joint Surg Am. 2006;88:21–4.
3. Buckwalter JA. Aging and degeneration of the human intervertebral disc.
Spine. 1995;20:1307–14.
4. Bogduk N. The lumbar disc and low back pain. Neurosurg Clin N Am.
1991;2:791–806.
5. Gruber HE, Hanley EN Jr. Analysis of aging and degeneration of the human
intervertebral disc: comparison of surgical specimens with normal controls.
Spine. 1998;23:751–7.
6. Roberts S, Urban JP, Evans H, Eisenstein SM. Transport properties of the
human cartilage endplate in relation to its composition and calcification.
Spine. 1996;21:415–20.
7. Stephan S, Johnson WE, Roberts S. The influence of nutrient supply and cell
density on the growth and survival of intervertebral disc cells in 3D culture.
Eur Cell Mater. 2011;22:97–108.
8. Urban JP, Smith S, Fairbank JC. Nutrition of the intervertebral disc. Spine.
2004;29:2700–9.
9. Park JB, Lee JK, Park SJ, Kim KW, Riew KD. Mitochondrial involvement in
Fas-mediated apoptosis of human lumbar disc cells. J Bone Joint Surg Am.
2005;87:1338–42.
10. Cohen HY, Miller C, Bitterman KJ, Wall NR, Hekking B, Kessler B, et al. Calorie
restriction promotes mammalian cell survival by inducing the SIRT1
deacetylase. Science. 2004;305:390–2.
Miyazaki et al. Arthritis Research & Therapy  (2015) 17:253 Page 11 of 12
11. Zeng L, Chen R, Liang F, Tsuchiya H, Murai H, Nakahashi T, et al. Silent
information regulator, Sirtuin 1, and age-related diseases. Geriatr Gerontol
Int. 2009;9:7–15.
12. Salminen A, Kaarniranta K. SIRT1: regulation of longevity via autophagy. Cell
Signal. 2009;21:1356–60.
13. Zhang Z, Kakutani K, Maeno K, Takada T, Yurube T, Doita M, et al. Expression
of silent mating type information regulator 2 homolog 1 and its role in
human intervertebral disc cell homeostasis. Arthritis Res Ther. 2011;13:R200.
14. Takayama K, Ishida K, Matsushita T, Fujita N, Hayashi S, Sasaki K, et al. SIRT1
regulation of apoptosis of human chondrocytes. Arthritis Rheum.
2009;60:2731–40.
15. Matsushita T, Sasaki H, Takayama K, Ishida K, Matsumoto T, Kubo S, et al.
The overexpression of SIRT1 inhibited osteoarthritic gene expression
changes induced by interleukin-1β in human chondrocytes. J Orthop Res.
2013;31:531–7.
16. Matsuzaki T, Matsushita T, Takayama K, Matsumoto T, Nishida K, Kuroda R,
et al. Disruption of Sirt1 in chondrocytes causes accelerated progression of
osteoarthritis under mechanical stress and during ageing in mice. Ann
Rheum Dis. 2014;73:1397–404.
17. Luo J, Nikolaev AY, Imai S, Chen D, Su F, Shiloh A, et al. Negative control of
p53 by Sir2α promotes cell survival under stress. Cell. 2001;107:137–48.
18. Vaziri H, Dessain SK, Ng Eaton E, Imai SI, Frye RA, Pandita TK, et al. hSIR2SIRT1
functions as an NAD-dependent p53 deacetylase. Cell. 2001;107:149–59.
19. Lee IH, Cao L, Mostoslavsky R, Lombard DB, Liu J, Bruns NE, et al. A role for
the NAD-dependent deacetylase Sirt1 in the regulation of autophagy. Proc
Natl Acad Sci U S A. 2008;105:3374–9.
20. Sasaki H, Takayama K, Matsushita T, Ishida K, Kubo S, Matsumoto T, et al.
Autophagy modulates osteoarthritis-related gene expression in human
chondrocytes. Arthritis Rheum. 2012;64:1920–8.
21. Kabuta T, Furuta A, Aoki S, Furuta K, Wada K. Aberrant interaction between
Parkinson disease-associated mutant UCH-L1 and the lysosomal receptor for
chaperone-mediated autophagy. J Biol Chem. 2008;283:23731–8.
22. Nixon RA, Wegiel J, Kumar A, Yu WH, Peterhoff C, Cataldo A, et al. Extensive
involvement of autophagy in Alzheimer disease: an immuno-electron
microscopy study. J Neuropathol Exp Neurol. 2005;64:113–22.
23. Pfirrmann CW, Metzdorf A, Zanetti M, Hodler J, Boos N. Magnetic resonance
classification of lumbar intervertebral disc degeneration. Spine.
2001;26:1873–8.
24. Park JB, Kim KW, Han CW, Chang H. Expression of Fas receptor on disc cells
in herniated lumbar disc tissue. Spine. 2001;26:142–6.
25. Rannou F, Lee TS, Zhou RH, Chin J, Lotz JC, Mayoux-Benhamou MA, et al.
Intervertebral disc degeneration: the role of the mitochondrial pathway in
annulus fibrosus cell apoptosis induced by overload. Am J Pathol.
2004;164:915–24.
26. Sudo H, Minami A. Caspase 3 as a therapeutic target for regulation of
intervertebral disc degeneration in rabbits. Arthritis Rheum. 2011;63:1648–57.
27. Sudo H, Minami A. Regulation of apoptosis in nucleus pulposus cells by
optimized exogenous Bcl-2 overexpression. J Orthop Res. 2010;28:1608–13.
28. Yurube T, Hirata H, Kakutani K, Maeno K, Takada T, Zhang Z, et al.
Notochordal cell disappearance and modes of apoptotic cell death in a rat
tail static compression-induced disc degeneration model. Arthritis Res Ther.
2014;16:R31.
29. Gruber HE, Norton HJ, Hanley EN Jr. Anti-apoptotic effects of IGF-1 and
PDGF on human intervertebral disc cells in vitro. Spine. 2000;25:2153–7.
30. Park JB, Park IC, Park SJ, Jin HO, Lee JK, Riew KD. Anti-apoptotic effects of
caspase inhibitors on rat intervertebral disc cells. J Bone Joint Surg Am.
2006;88:771–9.
31. Cheng HL, Mostoslavsky R, Saito S, Manis JP, Gu Y, Patel P, et al.
Developmental defects and p53 hyperacetylation in Sir2 homolog (SIRT1)-
deficient mice. Proc Natl Acad Sci U S A. 2003;100:10794–9.
32. Kroemer G, Marino G, Levine B. Autophagy and the integrated stress
response. Mol Cell. 2010;40:280–93.
33. Gonzalez-Polo RA, Boya P, Pauleau AL, Jalil A, Larochette N, Souquere S,
et al. The apoptosis/autophagy paradox: autophagic vacuolization before
apoptotic death. J Cell Sci. 2005;118:3091–102.
34. Degenhardt K, Mathew R, Beaudoin B, Bray K, Anderson D, Chen G, et al.
Autophagy promotes tumor cell survival and restricts necrosis,
inflammation, and tumorigenesis. Cancer Cell. 2006;10:51–64.
35. Apel A, Herr I, Schwarz H, Rodemann HP, Mayer A. Blocked autophagy
sensitizes resistant carcinoma cells to radiation therapy. Cancer Res.
2008;68:1485–94.
36. Amelio I, Melino G, Knight RA. Cell death pathology: cross-talk with
autophagy and its clinical implications. Biochem Biophys Res Commun.
2011;414:277–81.
37. Ravikumar B, Moreau K, Jahreiss L, Puri C, Rubinsztein DC. Plasma
membrane contributes to the formation of pre-autophagosomal structures.
Nat Cell Biol. 2010;12:747–57.
38. Shen C, Yan J, Jiang LS, Dai LY. Autophagy in rat annulus fibrosus cells:
evidence and possible implications. Arthritis Res Ther. 2011;13:R132.
39. Grunhagen T, Wilde G, Soukane DM, Shirazi-Adl SA, Urban JP. Nutrient
supply and intervertebral disc metabolism. J Bone Joint Surg Am.
2006;88:30–5.
40. Johnson WE, Stephan S, Roberts S. The influence of serum, glucose and
oxygen on intervertebral disc cell growth in vitro: implications for
degenerative disc disease. Arthritis Res Ther. 2008;10:R46.
Submit your next manuscript to BioMed Central
and take full advantage of: 
• Convenient online submission
• Thorough peer review
• No space constraints or color ﬁgure charges
• Immediate publication on acceptance
• Inclusion in PubMed, CAS, Scopus and Google Scholar
• Research which is freely available for redistribution
Submit your manuscript at 
www.biomedcentral.com/submit
Miyazaki et al. Arthritis Research & Therapy  (2015) 17:253 Page 12 of 12
